Estudo randomizado | Metilfenidato pode melhorar a apatia em pacientes com doença de Alzheimer.

Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial – JAMA Neurology (gratuito por tempo limitado)

Editorial: Methylphenidate for Apathy in Alzheimer Disease—Why Should We Care? (gratuito por tempo limitado)

Comentário no Twitter

Small to medium effects of methylphenidate for apathy in AD. Good to see a positive symptomatic treatment trial but I wonder just how important the improvements are to patients and their families. https://t.co/nGSxlAntAd

— Robert Howard (@ProfRobHoward) September 27, 2021